Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Alcohol Abuse in Schizophrenia
NCT00145847Phase 4Completed
- Sponsor
- Upstate Medical University
- Start
- Apr 2003
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in alcohol dependence and alcohol use disorder (AUD) comparing Naltrexone with Placebo (2 arms). Primary endpoint: Number of drinking days over the course of the treatment trial at 12 weeks. Started Apr 2003; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependencealcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT00145847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145847.